Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 15 | Issue 2 | 2025 | pp. 524–530Open access
Optimizing Encorafenib Validation: A Quality by Design Approach Empowered by Green Chemistry
- 1,
- 2,
- 3,
- 3,
- 3,
- 3,
- 1*
- 1 School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha, INDIA.
- 2 Department of Pharmacy, Bharat Institute of Technology, Mangalpally, Ibrahimpatnam, Telangana, INDIA.
- 3 Department of Pharmacy, ARKA JAIN University, Jamshedpur, Jharkhand, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Kirtimaya Mishra
School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha, INDIA.
Email: kirtimishra.pharma@gmail.com
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2025
- Received:
- Sep 19, 2024
- Accepted:
- Dec 23, 2024
- DOI:
- 10.5530/ijpi.20250120
How to cite
Jena, D., Jabeen, A., Mahato, A. D., Choudhary, K., Mahato, R., Chakraborty, P., & Mishra, K. (2025). Optimizing Encorafenib Validation: A Quality by Design Approach Empowered by Green Chemistry. International Journal of Pharmaceutical Investigation, 15(2), 524–530. https://doi.org/10.5530/ijpi.20250120
Abstract
Background
Green chemistry, also known as environmentally sustainable chemistry, is an area of study within a field of chemistry with the main goal of reducing the negative effects associated with chemical reactions and outcomes. Main aim is for fostering development of environmentally conscious as well as sustainable therapies by reducing/eliminating the employment of harmful chemical substances, limiting creation of dangerous substances and conserving energy and resources.
Materials and Methods
In this investigation, linearity was observed for Encorafenib (ENFB) at concentrations ranging from 2 to 12 μg/mL. The technique of solving simultaneous equations was applied in order to determine the drug concentrations.
Results and Discussion
The estimated recovery percentage from the chosen dosage form, capsules, with a sample size of six, was 100.4% with a Standard Deviation of ±0.028 (SD). The recovery rates of accuracy study, on average, fell between 99.8 and 101.05%. Throughout intra-day assessments, the observed percentage relative standard deviation, or %RSD, was continuously less than 2%, demonstrating a high level of accuracy in this recommended methodology. The outcome of validation process and the statistical analysis of these recommended methodologies show that the suggested processes can be implemented in the stimulated quality control laboratories.
Conclusion
The current method is regarded to be adequate for evaluating ENFB in capsule dosage formulation quantitatively since it successfully eradicates any possible interference from regularly used excipients. As a result, such procedure is applicable to a wide range of analytical purposes.
Keywords
Subject
Article metadata
| Title | Optimizing Encorafenib Validation: A Quality by Design Approach Empowered by Green Chemistry |
|---|---|
| Authors | Diptimayee Jena; Asra Jabeen; Akash Deep Mahato; Khush Choudhary; Roshan Mahato; Pakhi Chakraborty; Kirtimaya Mishra |
| Affiliations | School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha, INDIA.; Department of Pharmacy, Bharat Institute of Technology, Mangalpally, Ibrahimpatnam, Telangana, INDIA.; Department of Pharmacy, ARKA JAIN University, Jamshedpur, Jharkhand, INDIA. |
| Corresponding author | kirtimishra.pharma@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 15, Issue 2 (2025) |
Also in this issue
- A Comparative Review of 3D Printing Technologies and their Applications: A Systematic Review for Future of Medicine Fabricationpp. 313–324
- Precision Medicine in Diabetes Management: From Theory to Clinical Practicepp. 325–333
- Revolutionizing Healthcare: The Impact of AI on Precision Medicinepp. 334–360
- Review on Soluplus®: Pharmaceuticals Revolutionizing Drug Delivery and Formulation Strategiespp. 344–360
- Pharmaceutical Excipients: Functions, Selection Criteria, and Emerging Trendspp. 361–376